BSE Live
Oct 31, 16:01Prev. Close
323.85
Open Price
325.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:47Prev. Close
323.90
Open Price
324.10
Bid Price (Qty.)
325.40 (10)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Gufic Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 745.55 | 769.66 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 745.55 | 769.66 | |
| Total Operating Revenues | 819.81 | 806.67 | |
| Other Income | 3.63 | 2.18 | |
| Total Revenue | 823.43 | 808.84 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 344.20 | 331.26 | |
| Purchase Of Stock-In Trade | 55.41 | 58.06 | |
| Operating And Direct Expenses | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -24.91 | 0.57 | |
| Employee Benefit Expenses | 127.19 | 109.63 | |
| Finance Costs | 24.52 | 15.36 | |
| Depreciation And Amortisation Expenses | 21.06 | 17.02 | |
| Other Expenses | 181.82 | 161.27 | |
| Total Expenses | 729.29 | 693.17 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 94.14 | 115.67 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 94.14 | 115.67 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 18.72 | 28.40 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 5.75 | 3.17 | |
| Other Direct Taxes | 0.00 | 0.00 | |
| Total Tax Expenses | 24.49 | 29.54 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 69.65 | 86.14 | |
| Profit/Loss From Continuing Operations | 69.65 | 86.14 | |
| Profit/Loss For The Period | 69.65 | 86.14 | |
| Minority Interest | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 69.65 | 86.14 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 7.00 | 9.00 | |
| Diluted EPS (Rs.) | 7.00 | 9.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 1.00 | 0.97 | |
| Tax On Dividend | 0.00 | 0.00 |
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2024
Gufic Bio Consolidated September 2024 Net Sales at Rs 204.18 crore, down 4.98% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2024
Gufic Bio Consolidated September 2024 Net Sales at Rs 204.18 crore, down 4.98% Y-o-Y